低分子量肝素制剂日益被临床医师重视,我刊近几年已发表了包括那屈肝素钙、达肝素钠等多篇临床应用的论著。亭扎肝素钠(ｆｉｎｚａｐａｒｉｎｓｏｄｉｕｍ)是又一新低分子量肝素,由利奥公司开发,并已于1996年6月上市,商品名Ｉｎｎｏｈｅｐ。剂型分:小瓶———抗Ｘａ因子10000Ｉ Low molecular weight heparin preparations are increasingly valued by clinicians. In recent years, I published a series of articles including nadroparin calcium, dalteparin and many other clinical applications. Finzaparinsodium is another new low molecular weight heparin developed by Leo and marketed in June 1996 under the trade name Innohep. Formulation points: vial --- anti-Xa factor 10000I